Regentis Biomaterials Ltd. (RGNT)
$2.10+1.94%Close
SELL
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $8M
- Avg volume
- 5.4M
- Beta
- -0.69
- Short % float
- 1.57%
- Days to cover
- 1.0
- SI change
- -53.9%
- 1W
- +5.00%
- 1M
- +7.69%
- 3M
- -2.33%
- YTD
- -68.84%
- vs SPY 1W
- +6.37%
- vs SPY 1M
- +3.96%
- vs SPY 3M
- -5.42%
- vs SPY YTD
- -80.93%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SEERSELLSeer, Inc.RECOVERYQ -22$2.03+0.50%
- TLSABUYTiziana Life Sciences LtdRECOVERYQ 1$1.14+1.79%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.18-2.48%
- INABBUYIN8bio, Inc.RECOVERYQ -20$1.28+5.79%
- KYNBBUYKyntra Bio, Inc.RECOVERYQ -15$7.52+2.73%
- GOVXBUYGeoVax Labs, Inc.CRISISQ -19$0.65+8.33%
- ANTXBUYAN2 Therapeutics, Inc.RECOVERYQ -7$5.81+0.35%
- ENTABUYEnanta Pharmaceuticals, Inc.RECOVERYQ 13$13.47+2.59%
- PLSEBUYPulse Biosciences, Inc.BULLQ 26$50.42+5.37%
- VNRXSELLVolitionRx LimitedCRISISQ -10$0.42-4.55%
- ZCMDBUYZhongchao Inc.CRISISQ -39$0.93-3.12%
- ODTXBUYOdyssey Therapeutics, Inc.Q 80$26.39+6.97%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 4
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-107.5%
---
[VALUATION]
P/E TTM-
P/E FWD-
SECTOR PE22.60
INDUSTRY PE41.80
P/B-
P/FCF4.87
EV/EBITDA-
EV/EBIT-
PEG-
FCF YIELD20.54%
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
BETA-0.69
NET INCOME (TTM) < 0
